Elon Musk’s Trillion Dollars Sparks Debate Over Value
SpaceX’s blockbuster IPO propelled Elon Musk into a trillion-dollar spotlight. This piece explains what the milestone...
What Stocks Are New Investors Buying
Understanding what stocks are favored by new investors can guide your choices. Explore current buying trends to make informed decisions.
27,622 articles
Here Tuesday’s Wall Street: Top Analyst Calls Lift Tech
Stocks rose Tuesday as AI momentum outweighed inflation jitters, with fresh analyst calls on Autodesk, Celanese, DexC...
Minting Billion-Dollar Companies Faster: AI Surge
AI is accelerating the pace at which startups reach unicorn status, with policy shifts and market volatility adding c...
(SFL) 2026 Earnings Call: Insights for Investors
Discover what the (sfl) 2026 earnings call implies for revenue trends, balance sheet health, and the road ahead. This...
Sezzle Still Looks Attractive: A Fresh, Data-Driven Look
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
Which Optics Stock Dominated in 2026: AAOI, LITE, COHR
As AI data centers expand, three optics names have led the charge in 2026. Through May, AAOI has surged, while LITE a...
Bitcoin Pops 21-Month $60k on Soft Data Hope for Fed Pivot
Bitcoin rebounds to $60,000 as softer data calms rate-hike fears. This guide breaks down what moved prices, who’s buy...
Exclusive: We’re Spending Millions to Reform Defense Tech
A new defense startup is challenging traditional missiles with a car-like manufacturing model, backed by a $5 million...
SpaceX-Tesla Merger Valued at $3.4T, Yet Not Profitable
A speculative analysis explores a spacex-tesla merger valued at $3.4 trillion and explains why such a mega-deal might...
Dow’s Biggest Losers 2026: CRM, MSFT, UNH Drag Index
The Dow climbs while CRM, MSFT, and UNH slip, signaling a split market in 2026. This piece explains why the dow’s big...
Prediction: YTD Upside Deepens for Coca-Cola Stocks
Coca-Cola beat first-quarter 2026 expectations, raised guidance, and signaled margin improvement from an Africa dives...
It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status